The characteristics of ACS patients with and without MACEs were not significantly different, except for dyslipidemia, LVEF, receiving angiotensin-converting enzyme inhibitors (ACE-I) or angiotensin receptor blockers (ARB), and influenza vaccination (Table 1). The gene discussed is ACE; the disease is metabolic syndrome.